Industry Articles
Updates about sleep-related diagnostic devices, therapies, products and companies

Philips issues Dreamstation CPAP recall notification

Today Philips issued a recall notification for specific Philips bi-level positive airway pressure (bi-level PAP), continuous positive airway pressure (CPAP), and mechanical ventilator devices. The recall is in response to potential health risks related to the sound abatement foam component in these devices. The [...]

2021-06-19T12:45:40-05:00June 14th, 2021|Featured, Industry|

FDA authorizes emergency use for PortPatch CPAP mask filter

On Nov. 23 the U.S. Food and Drug Administration authorized the emergency use of the ventilator accessory PortPatch, which is intended to reduce the spread of airborne particulates through the exhalation ports, anti-asphyxia valves, and carbon dioxide vents on full-face or non-rebreathing CPAP masks [...]

2020-12-09T21:31:28-06:00December 9th, 2020|Industry|

FDA authorizes emergency use for Lumin on N95 respirators

On Dec. 3 the U.S. Food and Drug Administration authorized the emergency use of the Lumin LM3000 device for bioburden reduction of compatible N95 respirators that are contaminated or potentially contaminated with SARS-CoV-2 or other pathogenic microorganisms. The Lumin LM3000 utilizes ultraviolet germicidal irradiation [...]

2020-12-09T21:30:27-06:00December 4th, 2020|Industry|

FDA approves marketing of NightWare app to treat nightmares

On Nov. 6, 2020, the FDA permitted marketing of NightWare, an app that reduces sleep disturbances in adults 22 years of age or older who either have nightmare disorder or experience nightmares related to post-traumatic stress disorder. The FDA granted the marketing authorization to [...]

2021-02-06T17:08:07-06:00November 6th, 2020|Industry|

FDA approves expanded use of Wakix for narcolepsy

Harmony Biosciences announced on Oct. 13, 2020, that the U.S. Food and Drug Administration has approved Wakix (pitolisant) for the treatment of cataplexy in adult patients with narcolepsy. The FDA previously approved Wakix for the treatment of excessive daytime sleepiness in adult patients with [...]

2020-10-17T16:49:42-05:00October 17th, 2020|Industry|

FDA approves Xywav to treat narcolepsy

Jazz Pharmaceuticals announced July 22, 2020, that the U.S. Food and Drug Administration has approved the Xywav oral solution for the treatment of cataplexy or excessive daytime sleepiness in patients with narcolepsy who are 7 years of age and older. Multiple Xywav dosing options [...]

2020-10-21T11:09:35-05:00July 23rd, 2020|Industry|

New Apple Watch operating system includes sleep tracking

Apple announced this week that its latest version of the Apple Watch operating system will include sleep tracking features. According to the Apple press release, watchOS 7 will track sleep timing and duration through “the detection of micro-movements from the watch’s accelerometer, which signals [...]

2020-06-26T17:19:39-05:00June 26th, 2020|Industry|

Digital treatment for insomnia receives FDA clearance

The U.S. Food and Drug Administration has cleared the first prescription-based digital therapeutic for the treatment of chronic insomnia in adults, according to a press release from the product developer, Pear Therapeutics. Somryst, formerly SHUTi, uses cognitive behavioral therapy and data-based sleep restrictions to [...]

2020-03-26T22:32:34-05:00March 26th, 2020|Industry|